Education
About Us
Working with TipRanks
Follow Us
Vita Life Sciences Limited (AU:VLS)
ASX:VLS
VLS Stock Chart & Stats
AU$2.52
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$2.52
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$1.62 - AU$2.60
Previous CloseN/A
Volume18.65K
Average Volume (3M)14.76K
Market Cap
AU$139.28M
Enterprise ValueAU$106.63M
Total Cash (Recent Filing)AU$29.40M
Total Debt (Recent Filing)AU$2.25M
Price to Earnings (P/E)15.4
Beta0.08
Next Earnings
Feb 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.31%
Share Statistics
EPS (TTM)0.09
Shares Outstanding54,620,354
10 Day Avg. Volume12,408
30 Day Avg. Volume14,758
Financial Highlights & Ratios
PEG Ratio-2.13
Price to Book (P/B)2.10
Price to Sales (P/S)1.38
P/FCF Ratio18.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Vita Life Sciences Limited News
VLS FAQ
What was Vita Life Sciences Limited’s price range in the past 12 months?
Vita Life Sciences Limited lowest share price was AU$1.62 and its highest was AU$2.60 in the past 12 months.
What is Vita Life Sciences Limited’s market cap?
Vita Life Sciences Limited’s market cap is AU$139.28M.
When is Vita Life Sciences Limited’s upcoming earnings report date?
Vita Life Sciences Limited’s upcoming earnings report date is Feb 19, 2026 which is in 60 days.
How were Vita Life Sciences Limited’s earnings last quarter?
Vita Life Sciences Limited released its earnings results on Aug 24, 2025. The company reported AU$0.086 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.086.
Is Vita Life Sciences Limited overvalued?
According to Wall Street analysts Vita Life Sciences Limited’s price is currently Overvalued.
Does Vita Life Sciences Limited pay dividends?
Vita Life Sciences Limited pays a Semiannually dividend of AU$0.045 which represents an annual dividend yield of 4.31%. See more information on Vita Life Sciences Limited dividends here
What is Vita Life Sciences Limited’s EPS estimate?
Vita Life Sciences Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vita Life Sciences Limited have?
Vita Life Sciences Limited has 54,620,354 shares outstanding.
What happened to Vita Life Sciences Limited’s price movement after its last earnings report?
Vita Life Sciences Limited reported an EPS of AU$0.086 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.333%.
Which hedge fund is a major shareholder of Vita Life Sciences Limited?
Currently, no hedge funds are holding shares in AU:VLS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vita Life Sciences Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:VLS Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$323.4K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
23.60%
12-Months-Change
Fundamentals
Return on Equity
18.35%
Trailing 12-Months
Asset Growth
9.85%
Trailing 12-Months
Company Description
Vita Life Sciences Limited
Vita Life Sciences Limited (VLS) is a health and wellness company that specializes in the development and distribution of nutritional supplements and dietary products. The company operates primarily in the consumer health sector, focusing on providing high-quality vitamins, minerals, and herbal supplements. VLS aims to enhance the well-being of its customers through its innovative product offerings, which cater to various health needs and promote a balanced lifestyle.
Technical Analysis
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―
Cronos Australia Ltd.
―
Options Prices
Currently, No data available
---